The Journal of Clinical Pediatric Rheumatology
Online ISSN : 2434-608X
Print ISSN : 2435-1105
A pediatric case of Takayasu arteritis complicated with refractory ulcerative colitis undergoing total colectomy and tocilizumab treatment.
Yuko SugitaNami OkamotoYuka OzekiKosuke ShabanaTakeru OkuhiraEmiri KajiAtsushi YodenAkira Ashida
Author information
JOURNAL FREE ACCESS

2020 Volume 11 Issue 1 Pages 44-50

Details
Abstract
Takayasu arteritis( TA) and ulcerative colitis( UC) share many genetic factors, and coexistence of both are not uncommon. We report a case of TA in a 11-year-old girl with UC. She developed total colonic UC at the age of 8. While being treated with azathioprine (AZA) and infliximab (IFX), pain in the interior thigh during exercise and increased CRP were observed from age 11 years and 2 months old. No exacerbation of UC was found in colonoscopy at that time. Subsequently, pyrexia and malaise developed, and PET-CT showed accumulation in both subclavian arteries, leading to the diagnosis of TA. Methylprednisolone pulse therapy was performed and the dose of AZA was increased as an induction therapy. IFX was continued every 6 weeks. The vascular ultrasound findings worsened as the dose of PSL was tapered and IFX was changed to tocilizumab( TCZ) at the age of 12 years and 1 months. Thereafter, UC exacerbated and total colectomy was performed at the age of 12 years and 7 months. After the operation, vascular ultrasound findings improved and PSL is being tapered without relapse. TCZ is considered for maintenance therapy in PSL dependent TA patients, but efficacy of TCZ in UC is unclear. Since the overlap of TA and UC is not uncommon, it is necessary to seek the optimum treatment for TA with UC in the future.
Content from these authors
© 2020 Pediatric Rheumatology Association of Japan
Previous article Next article
feedback
Top